SRI LIQUID PROOF SURGICAL GOWN 7503

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06,07 report with the FDA on 2004-02-18 for SRI LIQUID PROOF SURGICAL GOWN 7503 manufactured by Sri/surgical Express, Inc..

Event Text Entries

[354580] Doctor reported experiencing strike through of fluids inside sleeve (cuff area) of a liquid proof surgical gown.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1527607-2004-00001
MDR Report Key525784
Report Source05,06,07
Date Received2004-02-18
Date of Report2004-02-05
Date of Event2004-01-06
Date Mfgr Received2004-01-06
Device Manufacturer Date2004-01-01
Date Added to Maude2004-05-21
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactJOYCE MOODY, DIR
Manufacturer Street12425 RACE TRACK ROAD
Manufacturer CityTAMPA FL 33626
Manufacturer CountryUS
Manufacturer Postal33626
Manufacturer Phone8138919550
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSRI LIQUID PROOF SURGICAL GOWN
Generic NameLARGE SURGICAL GOWN
Product CodeFYB
Date Received2004-02-18
Model NumberNA
Catalog Number7503
Lot NumberNOT REPORTED TO SRI
ID NumberBARCODE # NOT REPORTED TO SRI
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key514922
ManufacturerSRI/SURGICAL EXPRESS, INC.
Manufacturer Address7086 INDUSTRIAL ROW RD. MASON OH 45040 US
Baseline Brand NameLARGE LIQUID PROOF GOWN
Baseline Generic NameLIQUID PROOF SURGICAL GOWN
Baseline Model NoNA
Baseline Catalog No7503
Baseline IDNA
Baseline Device FamilyLIQUID PROOF SURGICAL GOWN
Baseline Shelf Life [Months]NA
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK920404
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2004-02-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.